Rasaratnam Brindhesha, Kaye David, Jennings Garry, Dudley Francis, Chin-Dusting Jaye
Alfred Hospital and Baker Medical Research Institute, Prahran, Victoria, Australia.
Ann Intern Med. 2003 Aug 5;139(3):186-93. doi: 10.7326/0003-4819-139-3-200308050-00008.
Peripheral vasodilatation is central to the pathogenesis of the accompanying hyperkinetic circulatory state and portal hypertension in cirrhotic patients. Selective intestinal decontamination with norfloxacin has been demonstrated to partially correct nitric oxide production in the forearm vasculature of cirrhotic patients.
To examine the effects of selective intestinal decontamination on regional and systemic hemodynamics in cirrhotic patients.
Randomized, double-blind, placebo-controlled, crossover study.
Alfred Hospital, Melbourne, Australia.
14 patients with alcohol-related cirrhosis and 14 matched healthy controls.
Norfloxacin, 400 mg twice daily, for 4 weeks.
Venous occlusion plethysmography was used to determine forearm blood flow. Cardiac output and the hepatic venous pressure gradient were determined after cardiac catheterization. Glomerular filtration rate was assessed by measuring inulin clearance. Serum levels of endotoxin were determined by chromogenic Limulus amebocytelysate assay.
Norfloxacin significantly diminished serum endotoxin levels (average change, -2.14 EU/mL [95% CI, -3.6 to -0.68 EU/mL]). Derived systemic vascular resistance increased significantly with norfloxacin (2.94 units [CI, 0.74 to 5.11 units]) and was accompanied by an increase in mean arterial pressure (8.70 mm Hg [CI, 2.65 to 14.73]), a trend toward decreased cardiac output (-1.207 L/min [range, 0.05 to -2.37 L/min]), a decrease in forearm blood flow (-0.99 mL/100 mL per min [CI, -1.80 to -0.17 mL/100 mL per min]), and a trend toward reduced hepatic venous pressure gradient (-2.43 mm Hg [CI, -5.2 to 0.34 mm Hg]). Norfloxacin did not significantly alter glomerular filtration rate.
Selective intestinal decontamination with norfloxacin partially reverses the hyperdynamic circulatory state in cirrhotic patients without harming splanchnic or renal hemodynamics.
外周血管舒张是肝硬化患者伴随的高动力循环状态和门静脉高压发病机制的核心。已证明用诺氟沙星进行选择性肠道去污可部分纠正肝硬化患者前臂血管系统中的一氧化氮生成。
研究选择性肠道去污对肝硬化患者局部和全身血流动力学的影响。
随机、双盲、安慰剂对照、交叉研究。
澳大利亚墨尔本阿尔弗雷德医院。
14例酒精性肝硬化患者和14例匹配的健康对照者。
诺氟沙星,每日两次,每次400mg,共4周。
采用静脉阻断体积描记法测定前臂血流量。心脏导管检查后测定心输出量和肝静脉压力梯度。通过测量菊粉清除率评估肾小球滤过率。采用显色鲎试剂法测定血清内毒素水平。
诺氟沙星显著降低血清内毒素水平(平均变化,-2.14 EU/mL[95%CI,-3.6至-0.68 EU/mL])。诺氟沙星使衍生的全身血管阻力显著增加(2.94单位[CI,0.74至5.11单位]),并伴有平均动脉压升高(8.70 mmHg[CI,2.65至14.73])、心输出量有降低趋势(-1.207 L/min[范围,0.05至-2.37 L/min])、前臂血流量减少(-0.99 mL/100 mL每分钟[CI,-1.80至-0.17 mL/100 mL每分钟])以及肝静脉压力梯度有降低趋势(-2.43 mmHg[CI,-5.2至0.34 mmHg])。诺氟沙星未显著改变肾小球滤过率。
用诺氟沙星进行选择性肠道去污可部分逆转肝硬化患者的高动力循环状态,而不损害内脏或肾脏血流动力学。